IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Hospitals and facilities in Texas

In 2025 Q1–Q4, the provider or facility offer prevailed in 87.3% of 83,292 determined Federal IDR dispute line items for hospitals and facilities in Texas. The median prevailing offer was 3.22x the QPA (25th–75th percentile 2.23x–4.14x; n = 71,585). The median time to a decision was 36 business days (n = 83,292).

Determined line items

83,292

2025 Q1–Q4 · 74 split decisions excluded

Provider win rate

87.3%

n = 83,292 · 2025 Q1–Q4

Median payment vs QPA

3.22x

middle half 2.23x–4.14x · n = 71,585 · 2025 Q1–Q4

Median days to decision

36

business days, from dispute initiation · n = 83,292 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q483,29287.3%3.22x2.23x–4.14x71,58536
2024 Q1–Q49,80884.4%2.96x1.61x–4.38x7,11030
2023 Q1–Q41,17764.1%2.00x1.00x–3.49x1,10862
2023 Q1–2025 Q494,27786.7%3.20x2.14x–4.16x79,803not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
99284 Emergency department visit with moderate level of medical decision making7,97986.6%3.09x7,82325
99285 Emergency department visit with high level of medical decision making5,90485.3%3.16x5,67334
85025 Complete blood cell count (red cells, white blood cell, platelets), automated te3,42388.2%3.33x2,90743
36415 Insertion of needle into vein for collection of blood sample3,37490.1%3.38x2,70745
99283 Emergency department visit with low level of medical decision making2,83680.9%3.54x2,73124
80053 Blood test, comprehensive group of blood chemicals2,05888.6%3.43x1,64270
81001 Manual urinalysis test with examination using microscope, automated1,79289.5%3.44x1,58147
93005 Routine electrocardiogram (ECG) using at least 12 leads with tracing1,70489.0%3.09x1,45043
84484 Troponin (protein) analysis, quantitative1,65388.3%3.13x1,41444
96374 Injection of drug or substance into vein1,62188.8%3.50x1,36042
80048 Blood test, basic group of blood chemicals (Calcium, total)1,46788.1%3.28x1,35025
96375 Injection of additional new drug or substance into vein1,32287.4%3.65x1,03344
71045 X-ray of chest, 1 view1,21089.0%3.01x1,10044
96372 Injection of drug or substance under skin or into muscle1,19589.9%2.63x96940
83690 Lipase (fat enzyme) level1,17287.0%3.60x1,00246
87804 Detection test by immunoassay with direct visual observation for influenza virus1,13487.5%3.01x1,04145
96361 Infusion into a vein for hydration, each additional hour1,05388.4%3.68x78943
81025 Urine pregnancy test85288.4%3.36x73246
81003 Automated urinalysis test72986.8%3.32x53941
70450 CT scan head or brain without contrast67789.1%3.68x56946

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Texas · Hospitals and facilities in all states

FAQ

What is the Federal IDR provider win rate for hospitals and facilities in Texas?

In 2025 Q1–Q4, the provider or facility offer was selected in 87.3% of 83,292 determined dispute line items for hospitals and facilities in Texas. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for hospitals and facilities in Texas?

In 2025 Q1–Q4, the median prevailing offer was 3.22x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 2.23x to 4.14x (n = 71,585 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for hospitals and facilities in Texas?

In 2025 Q1–Q4, the median was 36 business days (n = 83,292 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR